U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07633639) titled 'GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity' on May 18.
Brief Summary: Obese patients exhibit considerable heterogeneity and complex comorbidities, making long-term effective management challenging with monotherapy. While bariatric surgery remains the most effective weight-loss intervention, postoperative weight regain and metabolic deterioration remain significant concerns. glucagon-like peptide-1 receptor agonists (GLP-1RA) offer distinct advantages for weight loss and metabolic control, and their combination with surgery may produce synergistic effects. This study investigates the efficacy and safety of ...